Drug therapy in liver disease
Jorup-Rönström, C.
Lakartidningen 79(14): 1367-1369
1982
ISSN/ISBN: 0023-7205 PMID: 7087612 Document Number: 185901
Document emailed within 1 workday
Related Documents
Farrell, G.C.; Cooksley, W.G.; Hart, P.; Powell, L.W. 1978: Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism Gastroenterology 75(4): 580-588Ciancio, S.; Indirli, G.C.; Rizzo, F.T.; Elia, G.; Greco, F.; Perrone, C.; Chiriacò, G.; Greco, F.L.; Verdesca, V. 1993: Liver abscess: is drug therapy only possible? La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 15(6): 631-634
Fengler, D.; Baumgarten, R. 1993: Drug therapy in liver diseases Zeitschrift für Arztliche Fortbildung 87(5): 375-379
Kautzsch, E. 1971: Drug therapy of liver diseases Medizinische Monatsschrift 25(1): 15-17
Laake, K.; Borchgrevink, C.F. 1978: Drug-induced liver disease Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 98(3): 163-164
Gugenheim, J.; Samuel, D.; Saliba, F.; Castaing, D.; Bismuth, H. 1987: Use of flexible triple-drug immunosuppressive therapy in liver transplantation Transplantation Proceedings 19(5): 3805-3807
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
Breithaupt, H. 1994: Drug-induced liver damage caused by antirheumatic drugs--antirheumatic therapy in pre-existing liver damage Zeitschrift für Rheumatologie 53(4): 250-254
Wang, X.-L.; Yu, Z.-H.; Chen, S.-H.; Li, Y.-M. 2008: The clinical features and prognosis of drug-induced liver disease Zhonghua Nei Ke Za Zhi 47(5): 385-388
Helmstaedt, D.; May, B. 1975: Liver disease in drug addicts: frequency epidemiology and social importance International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 46-49
Beckmann, G.; Bader, W.; Berendes, J. 1970: Drug therapy of Menière's disease Hno 18(7): 199-202
Leuschner, U. 1992: Drug therapy of gallstone disease Schweizerische Rundschau für Medizin Praxis 81(29-30): 905-906
Stauch, M. 1979: The value of drug therapy in coronary disease ZFA. Zeitschrift für Allgemeinmedizin 55(28): 1577
Mule, A.; Sirohi, P.; Ram, N. 2018: Prevalence of Chronic Liver Disease Among the Patients of Celiac Disease and Effect of Gluten-Free Diet on Outcome of Liver Disease: a Prospective Study Journal of the Association of Physicians of India 66(3): 34-36
Pár, A.; Horváth, T.; Beró, T.; Kádas, I.; Pakodi, F.; Jávor, T. 1984: Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease Acta Physiologica Hungarica 64(3-4): 449-454
Paulsen, O.; Nilsson, L.M.; Sellin, M.; Osterlind, A.; Lundgren, M.; Fahlesson, P. 1983: Adverse effects and zimelidine therapy. Headache, muscle pain and liver involvement--a new disease entity in zimelidine therapy Lakartidningen 80(1-2): 31-32
Lacomblez, L. 1998: Drug therapy strategies in Alzheimer's disease La Revue du Praticien 48(17): 1913-1917
Naide, D. 1986: Drug therapy for peripheral arterial disease American Family Physician 34(3): 215-217
Cabré, E.; Gassull, M.A. 1994: Nutritional therapy in liver disease Acta Gastro-Enterologica Belgica 57(1): 1-12
Hasukić, S.; Zildzić, M. 1985: Drug therapy of ulcer disease in ambulatory care Medicinski Arhiv 39(5): 217-223